Vimarsana.com

Latest Breaking News On - Biomedical technology - Page 2 : vimarsana.com

Roivant's Anti-inflammatory Drug Succeeds in Mid-stage Study

Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's...

United-states
Bengaluru
Karnataka
India
Abbvie-humira
Bhanvi-satija
David-risinger
Shinjini-ganguli
Sumitomo-pharma
Pfizer
Roivant-sciences
Reuters

New NUS Research Institute in Guangzhou partners industry leaders in research, enterprise and talent development

The National University of Singapore Guangzhou Research Translation and Innovation Institute (NUS GRTII), a collaboration between NUS, the People’s Government of Guangzhou Municipality, and the China-Singapore Guangzhou Knowledge City Administrative

Singapore
Fuzhou
Fujian
China
Suzhou
Jiangsu
Tianjin
Chongqing
Guangzhou
Guangdong
Huangpu
Chinese

NUS Institute in Guangzhou Collaborates with Industry Leaders

NUS Institute in Guangzhou Collaborates with Industry Leaders
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Chongqing
China
Singapore
Huangpu
Guangdong
Suzhou
Jiangsu
Tianjin
Fuzhou
Fujian
Guangzhou
Chinese

Puck, play and friendship: Courtney Kollman's memory of this year's Crowchild Classic

Puck, play and friendship: Courtney Kollman's memory of this year's Crowchild Classic
thegauntlet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thegauntlet.ca Daily Mail and Mail on Sunday newspapers.

Calgary
Alberta
Canada
Mount-royal
Quebec
Adana-wood
Radhya-comar
Courtney-kollman
Scotiabank-saddledome
University-of-calgary
Biomedical-technology
Mount-royal-university

Will 2024 Be Easier on the Eyes?

Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon.

Chicago
Illinois
United-states
California
Washington
American
David-boyer
Reginald-sanders
Los-angeles
Drug-administration
American-society-of-retina-specialist
University-of-illinois-chicago

Drugmakers Plot Way Into Obesity Market With Deals and Development

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...

Germany
Denmark
San-francisco
California
United-states
German
Danish
Caroline-humer
Albert-bourla
Novo-nordisk-wegovy
Stefan-oelrich
Zealand-pharma

Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms

Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's...

Denmark
Cambridge
Cambridgeshire
United-kingdom
London
City-of
Massachusetts
United-states
Danish
Uli-stilz
David-evans
Khushi-mandowara

Study Links Specific Drugs to Delusions of Parasitosis Risk

Researchers conducted a case-control study of biometric and pharmaceutical data from 34 patients with delusions of parasitosis, which they compared to an age-matched control group of 53 women.

United-states
America
Brett-kopelan
Amryt-pharma
Web-community
Krystal-biotech
Chiesi-global-rare-diseases
Safety-study
Epidermolysis-bullosa
Wound-management
Ound-care
Delusions-of-parasitosis

FDA approves topical treatment for junctional, dystrophic EB

This is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023.

United-states
America
Amryt-pharma
Brett-kopelan
Web-community
Krystal-biotech
Chiesi-global-rare-diseases
Safety-study
Epidermolysis-bullosa
Wound-management
Ound-care
Wound

vimarsana © 2020. All Rights Reserved.